These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23669633)

  • 1. Synthesis and biological evaluation of 3-benzisoxazolyl-4-indolylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3β.
    Ye Q; Li M; Zhou Y; Pang T; Xu L; Cao J; Han L; Li Y; Wang W; Gao J; Li J
    Molecules; 2013 May; 18(5):5498-516. PubMed ID: 23669633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3beta (GSK-3beta) inhibitors.
    Ye Q; Xu G; Lv D; Cheng Z; Li J; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4302-12. PubMed ID: 19481464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of 7-azaindazolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors.
    Ye Q; Shen Y; Zhou Y; Lv D; Gao J; Li J; Hu Y
    Eur J Med Chem; 2013 Oct; 68():361-71. PubMed ID: 23994329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and evaluation of 3-aryl-4-pyrrolyl-maleimides as glycogen synthase kinase-3β inhibitors.
    Ye Q; Li M; Zhou YB; Cao JY; Xu L; Li YJ; Han L; Gao JR; Hu YZ; Li J
    Arch Pharm (Weinheim); 2013 May; 346(5):349-58. PubMed ID: 23585245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.
    Abdo Moustafa E; Abdelrasheed Allam H; Fouad MA; El Kerdawy AM; Nasser Eid El-Sayed N; Wagner C; Abdel-Aziz HA; Abdel Fattah Ezzat M
    Bioorg Chem; 2024 May; 146():107324. PubMed ID: 38569322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of thieno[3,2-c]pyrazol-urea derivatives as potent glycogen synthase kinase 3β inhibitors based on the DFG-out conformation.
    Yan N; Liu HY; Kong TT; Kong ZH; Li LY; Ma X; Zeng YL; Wang MJ; Tang LQ; Zhang CM; Liu ZP; Liu C
    Bioorg Med Chem Lett; 2024 Nov; 112():129932. PubMed ID: 39182737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3β.
    Yang Z; Liu H; Pan B; He F; Pan Z
    Org Biomol Chem; 2018 Jun; 16(22):4127-4140. PubMed ID: 29781013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation.
    Paris D; Ait-Ghezala G; Bachmeier C; Laco G; Beaulieu-Abdelahad D; Lin Y; Jin C; Crawford F; Mullan M
    J Biol Chem; 2014 Dec; 289(49):33927-44. PubMed ID: 25331948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors.
    Fukunaga K; Uehara F; Aritomo K; Shoda A; Hiki S; Okuyama M; Usui Y; Watanabe K; Yamakoshi K; Kohara T; Hanano T; Tanaka H; Tsuchiya S; Sunada S; Saito K; Eguchi J; Yuki S; Asano S; Tanaka S; Mori A; Yamagami K; Baba H; Horikawa T; Fujimura M
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6933-7. PubMed ID: 24176395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LiCl attenuates thapsigargin-induced tau hyperphosphorylation by inhibiting GSK-3β in vivo and in vitro.
    Fu ZQ; Yang Y; Song J; Jiang Q; Lin ZC; Wang Q; Zhu LQ; Wang JZ; Tian Q
    J Alzheimers Dis; 2010; 21(4):1107-17. PubMed ID: 21504119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells.
    Hu M; Waring JF; Gopalakrishnan M; Li J
    J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
    Kuo GH; Prouty C; DeAngelis A; Shen L; O'Neill DJ; Shah C; Connolly PJ; Murray WV; Conway BR; Cheung P; Westover L; Xu JZ; Look RA; Demarest KT; Emanuel S; Middleton SA; Jolliffe L; Beavers MP; Chen X
    J Med Chem; 2003 Sep; 46(19):4021-31. PubMed ID: 12954055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.
    Zhang HC; Ye H; Conway BR; Derian CK; Addo MF; Kuo GH; Hecker LR; Croll DR; Li J; Westover L; Xu JZ; Look R; Demarest KT; Andrade-Gordon P; Damiano BP; Maryanoff BE
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3245-50. PubMed ID: 15149684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel 4,5-bisindolyl-1,2,4-triazol-3-ones as glycogen synthase kinase-3β inhibitors and neuroprotective agents.
    Hu Y; Ruan W; Gao A; Zhou Y; Gao L; Xu M; Gao J; Ye Q; Li J; Pang T
    Pharmazie; 2017 Dec; 72(12):707-713. PubMed ID: 29441954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
    Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3β inhibitors and neuroprotective agents.
    Ye Q; Mao W; Zhou Y; Xu L; Li Q; Gao Y; Wang J; Li C; Xu Y; Xu Y; Liao H; Zhang L; Gao J; Li J; Pang T
    Bioorg Med Chem; 2015 Mar; 23(5):1179-88. PubMed ID: 25662701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
    Selenica ML; Jensen HS; Larsen AK; Pedersen ML; Helboe L; Leist M; Lotharius J
    Br J Pharmacol; 2007 Nov; 152(6):959-79. PubMed ID: 17906685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.
    Lanzillotta A; Sarnico I; Benarese M; Branca C; Baiguera C; Hutter-Paier B; Windisch M; Spano P; Imbimbo BP; Pizzi M
    J Mol Neurosci; 2011 Sep; 45(1):22-31. PubMed ID: 21181298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation.
    Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ
    CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.